During the past decade, Centro Brasileiro de Cirurgia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Brasileiro de Cirurgia" are "Diabetic Macular Edema" (2 trials). Many other conditions were trialed in "Centro Brasileiro de Cirurgia" in a lesser frequency.

Most popular intervention types in "Centro Brasileiro de Cirurgia" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Brasileiro de Cirurgia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Brasileiro de Cirurgia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Brasileiro de Cirurgia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Brasileiro de Cirurgia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".